Researchers studied the cumulative incidence and associated risk factors of keratinocyte carcinomas among patients who are survivors of childhood cancer.
Pharmanovia partners with Lindis Biotech to commercialise catmaxomab to treat rare condition, malignant ascites: Basildon, UK Thursday, November 21, 2024, 17:00 Hrs [IST] Pharmano ...